ADPT new logo.jpg
Adaptive Biotechnologies Reports First Quarter 2021 Financial Results
May 05, 2021 16:05 ET | Adaptive Biotechnologies
SEATTLE, May 05, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
ADPT new logo.jpg
Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference
April 27, 2021 16:05 ET | Adaptive Biotechnologies
SEATTLE, April 27, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
ADPT new logo.jpg
Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021
April 12, 2021 16:05 ET | Adaptive Biotechnologies
SEATTLE, April 12, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT)  a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
ADPT new logo.jpg
Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen
March 17, 2021 16:05 ET | Adaptive Biotechnologies
SEATTLE, March 17, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
ADPT new logo.jpg
Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection
March 05, 2021 18:44 ET | Adaptive Biotechnologies
First and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19 T-Detect COVID correctly confirmed recent or prior...
ADPT new logo.jpg
Adaptive Biotechnologies to Present at the Cowen 41st Annual Healthcare Conference
February 25, 2021 16:05 ET | Adaptive Biotechnologies
SEATTLE, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
ADPT new logo.jpg
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2020 Financial Results
February 24, 2021 16:05 ET | Adaptive Biotechnologies
SEATTLE, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
ADPT new logo.jpg
Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio
February 23, 2021 09:15 ET | Adaptive Biotechnologies
SEATTLE, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
ADPT new logo.jpg
Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
February 23, 2021 07:30 ET | Adaptive Biotechnologies
T-Detect is currently under review by the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) Patients can conveniently opt to visit one of nearly 2,000 Labcorp sites or...
ADPT new logo.jpg
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
February 02, 2021 16:05 ET | Adaptive Biotechnologies
SEATTLE, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT)  a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...